News
In a press release announcing the move, Novo Nordisk cited market challenges and its declining share price in a press release ...
Novo Nordisk CEO's ouster signals stiff competition in the obesity market, getting dominated by Eli Lilly, with Roche, ...
Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...
Indianapolis-based Eli Lilly & Co. announced promising results from a large study of its own tablet in diabetes patients last ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results